Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-04-10

Clinical Trial Update: Ganaxolone Treatment in Children With Fragile X Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on ganaxolone for Fragile X Syndrome in children; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ganaxolone (ganaxolone)

Snippet

Sponsor: Marinus Pharmaceuticals | Conditions: Fragile x Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2023-04-10